GI Motility Program News

News Releases

Below are news releases* and up-to-date information relating to gastrointestinal health, medical advances, promising research studies and the GI Motility Program at Cedars-Sinai Medical Center.

• Targeted Antibiotic Drug Safest Among Recommended Treatments for Irritable Bowel Disease, Study Finds (November 1, 2011)
• Cedars-Sinai Research Deepens Understanding of Most Common Gastrointestinal Disorder in U.S., Linking it to Bacterial Overgrowth, Food Poisoning (May 10, 2011)
• Research Shows Antibiotic Treatment Effective for Most Common Gastrointestinal Disorder in U.S. (January 6, 2011)

•  Cedars-Sinai Researchers Find Link Between Methane Production and Obesity (May 5, 2010)

• Study Shows That Targeted Antibiotics Lead to Prolonged Improvement in IBS Symptoms (October 17, 2006)
  
• Immune Signals Given by Variations of a Single Gene Are Associated with Increased Severity of Crohn's Disease, Particularly in Ashkenazi Jews (May 22, 2006)
  
• IBS Study Shows that Targeted Antibiotics Lead to Long-Lasting Improvement in Symptoms (November 8, 2005)
  

*You will need Adobe® Reader® to view and print these documents from your desktop. If you do not have this software, you can download it FREE from Adobe's website.